158 related articles for article (PubMed ID: 30769115)
1. Calcium Dobesilate and Micro-vascular diseases.
Liu J; Li S; Sun D
Life Sci; 2019 Mar; 221():348-353. PubMed ID: 30769115
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate-Free Radical Scavenger and Growth Factor Inhibition.
Haller H; Ji L; Stahl K; Bertram A; Menne J
Biomed Res Int; 2017; 2017():1909258. PubMed ID: 29082239
[TBL] [Abstract][Full Text] [Related]
3. Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
Solà-Adell C; Bogdanov P; Hernández C; Sampedro J; Valeri M; Garcia-Ramirez M; Pasquali C; Simó R
Curr Eye Res; 2017 Sep; 42(9):1273-1286. PubMed ID: 28574750
[TBL] [Abstract][Full Text] [Related]
4. Calcium dobesilate in the treatment of diabetic retinopathy.
Garay RP; Hannaert P; Chiavaroli C
Treat Endocrinol; 2005; 4(4):221-32. PubMed ID: 16053339
[TBL] [Abstract][Full Text] [Related]
5. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
Berthet P; Farine JC; Barras JP
Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
[TBL] [Abstract][Full Text] [Related]
6. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
8. Calcium Dobesilate Is Protective against Inflammation and Oxidative/Nitrosative Stress in the Retina of a Type 1 Diabetic Rat Model.
Voabil P; Liberal J; Leal EC; Bauer J; Cunha-Vaz J; Santiago AR; Ambrósio AF
Ophthalmic Res; 2017; 58(3):150-161. PubMed ID: 28793297
[TBL] [Abstract][Full Text] [Related]
9. Calcium dobesilate protects against d-galactose-induced hepatic and renal dysfunction, oxidative stress, and pathological damage.
Hakimizadeh E; Zamanian MY; Damankhorshid M; Giménez-Llort L; Sciorati C; Nikbakhtzadeh M; Moradbeygi K; Kujawska M; Kaeidi A; Taghipour Z; Fatemi I
Fundam Clin Pharmacol; 2022 Aug; 36(4):721-730. PubMed ID: 35112398
[TBL] [Abstract][Full Text] [Related]
10. Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice.
Njau F; Shushakova N; Schenk H; Wulfmeyer VC; Bollin R; Menne J; Haller H
PLoS One; 2020; 15(1):e0218494. PubMed ID: 31935212
[TBL] [Abstract][Full Text] [Related]
11. Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice.
Bogdanov P; Solà-Adell C; Hernández C; García-Ramírez M; Sampedro J; Simó-Servat O; Valeri M; Pasquali C; Simó R
J Diabetes Complications; 2017 Oct; 31(10):1481-1490. PubMed ID: 28847447
[TBL] [Abstract][Full Text] [Related]
12. [Calcium dobesilate].
Reuter H
Z Allgemeinmed; 1975 Feb; 51(6):292-3. PubMed ID: 1092080
[No Abstract] [Full Text] [Related]
13. In vitro effect of calcium dobesilate on oxidative/inflammatory stress in human varicose veins.
Alda O; Valero MS; Pereboom D; Serrano P; Azcona JM; Garay RP
Phlebology; 2011 Dec; 26(8):332-7. PubMed ID: 21705478
[TBL] [Abstract][Full Text] [Related]
14. Calcium Dobesilate Prevents Diabetic Kidney Disease by Decreasing Bim and Inhibiting Apoptosis of Renal Proximal Tubular Epithelial Cells.
Cai T; Wu XY; Zhang XQ; Shang HX; Zhang ZW; Liao L; Dong JJ
DNA Cell Biol; 2017 Apr; 36(4):249-255. PubMed ID: 28151018
[TBL] [Abstract][Full Text] [Related]
15. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
[TBL] [Abstract][Full Text] [Related]
16. [Action of calcium dobesilate (Doxium) on ocular vasculopathies].
Glăvan II; David M; Videa V; Dorcea I; Popescu-Vicea F
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1976; 20(4):305-6. PubMed ID: 138905
[No Abstract] [Full Text] [Related]
17. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
[TBL] [Abstract][Full Text] [Related]
18. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
[TBL] [Abstract][Full Text] [Related]
19. Calcium dobesilate: A drug treatment for diabetic retinopathy can negatively interfere with the measurement of glycated albumin using the enzymatic method.
Guo X; Zhao F; Yin Y; Wang D; Hou L; Wu J; Li D; Cheng X; Xia L; Xu E; Qiu L
Clin Chim Acta; 2018 Aug; 483():1-5. PubMed ID: 29653084
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of choroidal angiogenesis by calcium dobesilate in normal Wistar and diabetic GK rats.
Lameynardie S; Chiavaroli C; Travo P; Garay RP; Parés-Herbuté N
Eur J Pharmacol; 2005 Mar; 510(1-2):149-56. PubMed ID: 15740736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
